SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Gaillard Pieter)
 

Sökning: WFRF:(Gaillard Pieter) > In vivo Functional ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003493naa a2200421 4500
001oai:DiVA.org:uu-267583
003SwePub
008151124s2016 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2675832 URI
024a https://doi.org/10.1007/s11095-015-1774-32 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Lindqvist, Annika,d 1983-u Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Translational PKPD4 aut0 (Swepub:uu)annbo297
2451 0a In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes
264 c 2015-08-15
264 1b Springer Science and Business Media LLC,c 2016
338 a print2 rdacarrier
520 a Purpose:The purpose of this study was to evaluate formulation factors causing improvement in brain delivery of a small peptide after encapsulation into a targeted nanocarrier in vivo.Methods:The evaluation was performed in rats using microdialysis, which enabled continuous sampling of the released drug in both the brain (striatum) and blood. Uptake in brain could thereby be studied in terms of therapeutically active, released drug.Results:We found that encapsulation of the peptide DAMGO in fast-releasing polyethylene glycol (PEG)ylated liposomes, either with or without the specific brain targeting ligand glutathione (GSH), doubled the uptake of DAMGO into the rat brain. The increased brain delivery was observed only when the drug was encapsulated into the liposomes, thus excluding any effects of the liposomes themselves on the blood-brain barrier integrity as a possible mechanism. The addition of a GSH coating on the liposomes did not result in an additional increase in DAMGO concentrations in the brain, in contrast to earlier studies on GSH coating. This may be caused by differences in the characteristics of the encapsulated compounds and the composition of the liposome formulations. Conclusions:We were able to show that encapsulation into PEGylated liposomes of a peptide with limited brain delivery could double the drug uptake into the brain without using a specific brain targeting ligand.  
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmaceutiska vetenskaper0 (SwePub)301012 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmaceutical Sciences0 (SwePub)301012 hsv//eng
653 a Brain delivery
653 a liposomes
653 a blood-brain barrier
653 a microdialysis
653 a opioid peptide
653 a Farmakokinetik och läkemedelsterapi
653 a Pharmacokinetics and Drug Therapy
700a Rip, Jaap4 aut
700a van Kregten, Joan4 aut
700a Gaillard, Pieter J4 aut
700a Hammarlund-Udenaes, Margaretau Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Translational PKPD4 aut0 (Swepub:uu)marghamm
710a Uppsala universitetb Institutionen för farmaceutisk biovetenskap4 org
773t Pharmaceutical researchd : Springer Science and Business Media LLCg 33:1, s. 177-185q 33:1<177-185x 0724-8741x 1573-904X
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-267583
8564 8u https://doi.org/10.1007/s11095-015-1774-3

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy